Remove trial restrictions Start for $1

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Moodys
Boehringer Ingelheim
McKesson
AstraZeneca

Last Updated: May 17, 2022

CHILDREN'S MOTRIN COLD Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Children's Motrin Cold, and when can generic versions of Children's Motrin Cold launch?

Children's Motrin Cold is a drug marketed by J And J Consumer Inc and is included in one NDA.

The generic ingredient in CHILDREN'S MOTRIN COLD is ibuprofen; pseudoephedrine hydrochloride. There are sixty-four drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the ibuprofen; pseudoephedrine hydrochloride profile page.

Summary for CHILDREN'S MOTRIN COLD
Drug patent expirations by year for CHILDREN'S MOTRIN COLD
Recent Clinical Trials for CHILDREN'S MOTRIN COLD

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Le Bonheur Children's HospitalPhase 4
The Campbell FoundationPhase 4
University of ManitobaPhase 2

See all CHILDREN'S MOTRIN COLD clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for CHILDREN'S MOTRIN COLD
C01CA Adrenergic and dopaminergic agents
C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01 CARDIAC THERAPY
C Cardiovascular system
C01EB Other cardiac preparations
C01E OTHER CARDIAC PREPARATIONS
C01 CARDIAC THERAPY
C Cardiovascular system
G02CC Antiinflammatory products for vaginal administration
G02C OTHER GYNECOLOGICALS
G02 OTHER GYNECOLOGICALS
G Genito-urinary system and sex hormones
M01AE Propionic acid derivatives
M01A ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
M Musculo-skeletal system
M02AA Antiinflammatory preparations, non-steroids for topical use
M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M Musculo-skeletal system
R01AA Sympathomimetics, plain
R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01 NASAL PREPARATIONS
R Respiratory system
R01AB Sympathomimetics, combinations excl. corticosteroids
R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01 NASAL PREPARATIONS
R Respiratory system
R01BA Sympathomimetics
R01B NASAL DECONGESTANTS FOR SYSTEMIC USE
R01 NASAL PREPARATIONS
R Respiratory system
R02AX Other throat preparations
R02A THROAT PREPARATIONS
R02 THROAT PREPARATIONS
R Respiratory system
R03CA Alpha- and beta-adrenoreceptor agonists
R03C ADRENERGICS FOR SYSTEMIC USE
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R Respiratory system
S01FB Sympathomimetics excl. antiglaucoma preparations
S01F MYDRIATICS AND CYCLOPLEGICS
S01 OPHTHALMOLOGICALS
S Sensory organs

US Patents and Regulatory Information for CHILDREN'S MOTRIN COLD

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc CHILDREN'S MOTRIN COLD ibuprofen; pseudoephedrine hydrochloride SUSPENSION;ORAL 021128-001 Aug 1, 2000 OTC Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for CHILDREN'S MOTRIN COLD

See the table below for patents covering CHILDREN'S MOTRIN COLD around the world.

Country Patent Number Title Estimated Expiration
Colombia 5160329 METODO PARA PROVEER ABSORCION INCREMENTADA DE UNA AMINA FAR- MACEUTICAMENTE ACEPTABLE EN LA SANGRE DE UN HUMANO Y COMPOSI CION QUE COMPRENDE UNA AMINA FARMACEUTICAMENTE UN FARMACO ANTIINFLAMATORIO NO ESTEROIDAL See Plans and Pricing
Brazil 0002607 See Plans and Pricing
Saudi Arabia 534 تراكيب سائلة سريعة الامتصاص RAPIDLY ABSORBED See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Mallinckrodt
Colorcon
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.